Loading
Anhui Huangshan Capsule Co., Ltd. Stock: price and insider trades · China
黄山胶囊
Anhui Huangshan Capsule Co., Ltd.: what insiders have been doing
Insider filings for Anhui Huangshan Capsule Co., Ltd. are scarce in the SSE / SZSE (CSRC) feed, the latest one published on 30 June 2025. This page will fill in as new trades are disclosed. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€375,804
1 ops. · all time
Who traded when
BuySale叶松林1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 9,001 of 24,148 companies
57.9
score / 100
Value48
Quality68
FCF yld4.0%
Earn yld3.2%
EV/EBITDA16.7x
ROE6.1%
Gross mgn30%
Net mgn14%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥6.80
Analyst consensus
Income statement
RevenueCN¥460.4M
Gross profitCN¥137M30% margin
EBITDACN¥121.7M26% margin
Net incomeCN¥65M14.6% margin
Valuation
PER (trailing)34.0x
P/Book2.1x
Beta0.26
Balance sheet & cash
Market capCN¥2B
Total debtCN¥21.6k
Free Cash FlowCN¥81M
Debt / Equity0%
Profitability & ownership
ROE6.1%
ROA3.0%
% insiders46.0%
% institutions3.9%
Last declaration on 30 June 2025
About Anhui Huangshan Capsule Co., Ltd.
黄山胶囊 is a company specializing in the production of pharmaceutical products, including capsules and herbal medicines. It is listed on the XSHE market.
